Written and maintained by CASRAI Editorial Board
Last updated
BMC Infectious Diseases is an open access, peer-reviewed journal covering the prevention, diagnosis and management of infectious and sexually transmitted diseases. This fact sheet is for researchers deciding whether to cite or submit to it: it sets out the publisher’s own scope statement, the metrics the journal page displays, and the indexing record held by the US National Library of Medicine. Facts were read on 2026-11-08 and can change.
What BMC Infectious Diseases is
The journal’s aims and scope page describes it as an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans and animals, as well as related molecular genetics, pathophysiology and epidemiology. It is published under the BioMed Central (BMC) imprint, and its electronic ISSN is 1471-2334 (NLM Catalog). It began publishing in 2001.
Searchers also type BMC Infectious Disease (singular). This is the same journal; there is no separate title.
Scope, publisher and who runs it
The aims and scope page lists these topic areas: bacterial and fungal diseases; healthcare-associated infection control; hepatitis and co-infections; HIV and co-infections; parasitological diseases; sexually transmitted diseases; tuberculosis and other mycobacterial diseases; vaccines; and viral diseases. The journal home page names Natasha Hirst (MSc, PhD) as lead editor and lists an editorial board under the journal’s About menu.
The BMC Series selection criterion
The journal is part of the BMC Series. Its scope page states: “As a BMC Series journal, BMC Infectious Diseases does not make editorial decisions based on the perceived interest or potential impact of a study. Manuscripts are considered for publication if they are scientifically valid.” For research articles the page asks for a defined research question, sound methodology and analysis, and adherence to community-agreed standards. This differs from journals that select on perceived novelty or significance, and it is the main thing to weigh when matching a manuscript to the journal. For background on how reviewers are involved, see peer review.
Indexing and metrics, side by side
| Item | What the source states | Source (read 2026-11-08) |
|---|---|---|
| Indexing | Indexed in PubMed, Web of Science (SCIE), Scopus, DOAJ and more | Journal home page |
| NLM status | Currently indexed for MEDLINE, PubMed and PMC, from volume 1 (2001) | NLM Catalog |
| MeSH headings | Communicable Diseases; Sexually Transmitted Diseases | NLM Catalog |
| Journal Impact Factor | 3.2 (2025); 5-year 3.3 (2025) | Journal home page |
| Submission to first decision (median) | 7 days | Journal home page |
| Downloads | 13.2 million (2025) | Journal home page |
The impact factor and speed figures are the journal’s own display and are attributed as such. Third-party aggregator sites often show different numbers because they cite different years; check the year before quoting. For what the measure does and does not capture, see journal impact factor; for a comparable page on another infectious diseases title, see Clinical Infectious Diseases impact factor.
Where to find author information
The old bmcinfectdis.biomedcentral.com address now redirects: BMC journals have moved to Springer Nature Link, and the journal lives at link.springer.com/journal/12879. On that page, the About this journal menu holds Aims and scope, Editorial board, Editorial policies, Ethics and disclosures, Rights and permissions and Contact. The For authors menu holds the Pre-submission checklist, Submission guidelines, How to publish with us, Fees and funding, Calls for papers and Language editing, and a Submit your manuscript button. Fees are set out under Fees and funding; check that page for the current article-processing charge, since this page does not quote one. The journal page lists open calls for papers with 2027 deadlines, including Lyme borreliosis and beyond (7 July 2027), emerging zoonotic diseases (30 June 2027) and combatting AMR in infectious disease management (30 June 2027).
Strengths and limits
- Strength: broad scope across human and animal infectious disease, with the topic list above.
- Strength: indexed in PubMed/MEDLINE/PMC, Web of Science (SCIE), Scopus and DOAJ per the sources above.
- Strength: a soundness-based criterion rather than a perceived-impact one.
- Limit: open access publishing carries fees, so authors should read the Fees and funding page and any funder or institutional agreements first; see open access.
- Limit: a modest impact factor (3.2 in the journal’s own 2025 figure) for a journal of this breadth; whether that matters depends on your funder’s or institution’s assessment policy.
For a comparable journal fact sheet in another field, see Frontiers in Medicine: scope, sections, fees and indexing.
Frequently asked questions
Is BMC Infectious Disease the same as BMC Infectious Diseases?
Yes. The journal title is plural, BMC Infectious Diseases; the singular is a common search variant for the same journal (ISSN 1471-2334).
Who publishes BMC Infectious Diseases?
The NLM Catalog lists BioMed Central, London, as publisher, with a start year of 2001. The journal’s pages are now hosted on Springer Nature Link.
Is BMC Infectious Diseases open access?
Yes. The aims and scope page describes it as an open access journal.
Is it indexed in PubMed?
Yes. The NLM Catalog shows it currently indexed for MEDLINE, PubMed and PMC from volume 1 (2001), and the journal page also lists Web of Science (SCIE), Scopus and DOAJ.
What is its impact factor?
The journal page shows a Journal Impact Factor of 3.2 and a 5-year figure of 3.3, both for 2025, as read on 2026-11-08.
Sources
- BMC Infectious Diseases, Aims and scope, Springer Nature Link: link.springer.com/journal/12879/aims-and-scope (read 2026-11-08)
- BMC Infectious Diseases, journal home page: link.springer.com/journal/12879 (read 2026-11-08)
- NLM Catalog record for BMC Infectious Diseases, ISSN 1471-2334 (read 2026-11-08)
